Cerevel Therapeutics Holdings Inc
NASDAQ:CERE

Watchlist Manager
Cerevel Therapeutics Holdings Inc Logo
Cerevel Therapeutics Holdings Inc
NASDAQ:CERE
Watchlist
Price: 44.96 USD 0.74% Market Closed
Market Cap: 8.2B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CERE.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CERE Intrinsic Value
Not Available
Base Case Scenario
Compare CERE to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CERE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cerevel Therapeutics Holdings Inc

Current Assets 859.6m
Cash & Short-Term Investments 846.3m
Receivables 5m
Other Current Assets 8.3m
Non-Current Assets 267.8m
Long-Term Investments 218.6m
PP&E 44.6m
Other Non-Current Assets 4.6m
Current Liabilities 84.1m
Accounts Payable 10.8m
Accrued Liabilities 71.7m
Other Current Liabilities 1.5m
Non-Current Liabilities 478.8m
Long-Term Debt 337.9m
Other Non-Current Liabilities 140.9m
Efficiency

Free Cash Flow Analysis
Cerevel Therapeutics Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cerevel Therapeutics Holdings Inc

Revenue
0 USD
Cost of Revenue
-21.6m USD
Gross Profit
-21.6m USD
Operating Expenses
-468.8m USD
Operating Income
-490.4m USD
Other Expenses
29.9m USD
Net Income
-460.5m USD
Fundamental Scores

CERE Profitability Score
Profitability Due Diligence

Cerevel Therapeutics Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

Cerevel Therapeutics Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CERE Solvency Score
Solvency Due Diligence

Cerevel Therapeutics Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
hidden
Solvency
Score

Cerevel Therapeutics Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CERE Price Targets Summary
Cerevel Therapeutics Holdings Inc

There are no price targets for CERE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cerevel Therapeutics Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CERE is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CERE Insider Trading
Buy and sell transactions by insiders

CERE News

Other Videos